U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07060248) titled 'A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.' on June 23.
Brief Summary: To evaluate the efficacy of CT-based radiomics in differentiating benign from malignant renal tumors, predicting nuclear grading of renal cell carcinoma, and assessing T-stage of renal tumors, thereby exploring its clinical application value.
Study Start Date: Jan. 01
Study Type: OBSERVATIONAL
Condition:
Renal Cell Carcinoma (RCC)
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Second Xiangya Hospital of Central South University
Published by HT Digital Content Services with per...